208 related articles for article (PubMed ID: 1531976)
1. Modification of alkylating agent induced cell kill by 2-nitroimidazoles in unclamped and clamped SC 9L tumors.
Wallen CA; Moore SK; Wheeler KT
Int J Radiat Oncol Biol Phys; 1992; 22(4):727-30. PubMed ID: 1531976
[TBL] [Abstract][Full Text] [Related]
2. 2-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells.
Wong KH; Wallen CA; Wheeler KT
J Neurooncol; 1991 Aug; 11(1):17-25. PubMed ID: 1833513
[TBL] [Abstract][Full Text] [Related]
3. Effect of administration schedules on the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by misonidazole in subcutaneous 9L tumors.
Wong KH; Zhang H; Wallen CA; Wheeler KT
Int J Radiat Oncol Biol Phys; 1992; 23(4):831-9. PubMed ID: 1618675
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
Wong KH; Wallen CA; Wheeler KT
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of combination chemotherapy by nitroheterocyclics.
Siemann DW; Allalunis-Turner MJ
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):129-34. PubMed ID: 3391809
[TBL] [Abstract][Full Text] [Related]
6. [Recent advances in hypoxic cell radiosensitizer].
Ono K; Takahashi M; Nishidai T; Shibamoto Y; Abe M
Gan No Rinsho; 1983 Oct; 29(13):1608-12. PubMed ID: 6230470
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of misonidazole chemosensitization effect by mild local hyperthermia.
Wong KH; Urano M
Int J Radiat Oncol Biol Phys; 1992; 23(3):593-8. PubMed ID: 1612960
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of normal and malignant tissue to cyclophosphamide by nitroimidazoles with different partition coefficients.
Hirst DG; Hazlehurst JL; Brown JM
Br J Cancer; 1984 Jan; 49(1):33-42. PubMed ID: 6229264
[TBL] [Abstract][Full Text] [Related]
9. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
Yu NY; Brown JM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in rats bearing unclamped and clamped 9L subcutaneous tumors.
Wong KH; Wallen CA; Wheeler KT
Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):135-43. PubMed ID: 2745188
[TBL] [Abstract][Full Text] [Related]
11. The effect of timing on chemosensitization by clinical levels of SR-2508.
Hirst DG; Horsman MR; Brown JM; Hazlehurst JL
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1641-5. PubMed ID: 6237082
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
McNally NJ; Hinchliffe M; de Ronde J
Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
[TBL] [Abstract][Full Text] [Related]
13. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
Law MP; Hirst DG; Brown JM
Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
Hinchliffe M; McNally NJ
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1635-40. PubMed ID: 6237081
[TBL] [Abstract][Full Text] [Related]
15. Chemopotentiation in vivo: no loss of sensitization with fractionation.
Hill SA; Siemann DW
Br J Cancer; 1984 Oct; 50(4):509-17. PubMed ID: 6487517
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of radiosensitizers in combination with chemotherapeutic agents in solid tumors.
Clement JJ; Johnson RK
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):631-4. PubMed ID: 7107387
[TBL] [Abstract][Full Text] [Related]
17. Effect of thiol manipulation on chemopotentiation by nitroimidazoles.
Siemann DW; Flaherty AA; Penney DP
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1341-5. PubMed ID: 2715088
[TBL] [Abstract][Full Text] [Related]
18. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Milas L; Ito H; Hunter N
Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
Brown DM; Dionet C; Brown JM
Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
